Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-97-001513
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
21
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 MILLENNIUM PHARMACEUTICALS, INC. 10-K405 130330
2 COLLABORATIVE RESEARCH AGREEMENT EX-10.40 52266
3 LICENSE OPTION, LICENSE AND ROYALTY AGREEMENT EX-10.41 48482
4 COLLABORATIVE RESEARCH & LICENSE AGREEMENT EX-10.42 128657
5 LICENSE AGREEMENT EX-10.43 70596
6 MASTER AGREEMENT EX-10.44 170410
7 AMENDMENT TO MASTER AGREEMENT EX-10.45 4068
8 OMNIBUS AMENDMENT AGREEMENT EX-10.46 15689
9 CONSULTING AND INTERIM SERVICES AGREEMENT EX-10.47 35502
10 CONFIDENTIALITY & NON COMPETITION AGREEMENT EX-10.48 18959
11 STANDARD FORM COMMERCIAL LEASE EX-10.49 49678
12 FORM OF SUBLEASE AGREEMENT EX-10.50 45059
13 AMENDMENT, CONSENT & WAIVER EX-10.51 11349
14 LETTER AGREEMENT BET. CHEMGENICS, PFIZER & CO. EX-10.52 4235
15 LETTER AGREEMENT, CHEMGENICS, PERSEPTIVE, & CO. EX-10.53 31231
16 AMENDMENT TO COLLABORATIVE RESEARCH & LICENSE AGR. EX-10.54 5878
17 COMPUTATION OF PER SHARE EARNINGS EX-11.1 1227
18 MILLENIUM PHARMACEUTICALS 1996 ANNUAL REPORT EX-13 71521
19 LIST OF SUBSIDIARIES EX-21 360
20 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS EX-23 1434
21 FINANCIAL DATA SCHEDULE EX-27 2211
  Complete submission text file 0000950135-97-001513.txt   902736
Mailing Address
Business Address 640 MEMORIAL DRIVE CAMBRIDGE MA 02139 6176797000
MILLENNIUM PHARMACEUTICALS INC (Filer) CIK: 0001002637 (see all company filings)

EIN.: 043177038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-28494 | Film No.: 97569164
SIC: 2834 Pharmaceutical Preparations